Sundrug CoSDGCF 82 Pretax Margin % is 6.10% as of Dec. 2025, which is 10% above its 10-year median of 5.55. GuruFocus rates SDGCF with a GF Score™ of 82/100 and a GF Value™ of $34.93. The stock has 1 warning sign investors should review. Among 668 Healthcare Providers & Services companies, Sundrug Co ranks better than 56.44% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Sundrug Co's Pre-Tax Income for the
three
months ended in Dec. 2025 was $85 Mil. Sundrug Co's Revenue for the
three
months ended in Dec. 2025 was $1,394 Mil. Therefore, Sundrug Co's pretax margin for the quarter that ended in Dec. 2025 was 6.10%.
The historical rank and industry rank for Sundrug Co's Pretax Margin % or its related term are showing as below:
SDGCF'
s Pretax Margin % Range Over the Past 10 Years
Min: 5.35 Med: 5.55 Max: 6.51
Current: 5.44
SDGCF's Pretax Margin % is ranked better than 56.44% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 3.97
vs SDGCF: 5.44
Sundrug Co (OTCPK:SDGCF) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Sundrug Co Pretax Margin % Related Terms
Sundrug Co Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Sundrug Co's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Sundrug Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sundrug Co Pretax Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sundrug Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Sundrug Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sundrug Co (SDGCF) has a Pretax Margin % of 6.10% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Sundrug Co and its competitors. This is 10% above median its historical median of 5.55. Over the past decade, Sundrug Co's Pretax Margin % has ranged from 5.35 to 6.51. According to the industry distribution chart, Sundrug Co ranks #291 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 43.6%.
Is Sundrug Co's Pretax Margin % too high?
Sundrug Co's current Pretax Margin % of 6.10% is 10% above median its 10-year median of 5.55. Over the past 10 years, this metric has ranged from a low of 5.35 to a high of 6.51. The Healthcare Providers & Services industry median Pretax Margin % is 3.97. Sundrug Co's value of 6.10% is 53.7% above this industry median. Based on the distribution chart, Sundrug Co ranks #291 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Sundrug Co has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does Sundrug Co's Pretax Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Sundrug Co ranks #291 out of 668 companies for Pretax Margin %. This puts Sundrug Co in the upper half of its industry. The industry median Pretax Margin % is 3.97. Sundrug Co's value of 6.10% is 53.7% above this benchmark. Historically, Sundrug Co's own Pretax Margin % has ranged from 5.35 to 6.51 over the past decade. While the company's 10-year median is 5.55 vs. the industry median of 3.97, Sundrug Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 3.97, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sundrug Co's current Pretax Margin % of 6.10% is 53.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Sundrug Co and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 3.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sundrug Co's current Pretax Margin % is 6.10%, which is 10% above median its own 10-year median of 5.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sundrug Co stock overvalued right now?
Sundrug Co (SDGCF) has a current Pretax Margin % of 6.10%. The stock's GF Value™ is $34.93, compared to a current price of $28.18 — trading 19.3% below its estimated fair value. The current Pretax Margin % is 6.10%, which is 10% above median its 10-year median of 5.55 and 53.7% above the Healthcare Providers & Services industry median of 3.97. Sundrug Co's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Sundrug Co (SDGCF), the current Pretax Margin % is 6.10% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sundrug Co (SDGCF) Overvalued in 2026?
Based on GuruFocus' analysis, Sundrug Co stock appears to be undervalued.
The current stock price of $28.18 is trading 19.3% below its estimated GF Value™ of $34.93.
Key valuation signals for SDGCF:
Pretax Margin %: 6.10% (10% above median its 10-year median of 5.55)
GF Value™: $34.93 vs. price of $28.18 (19.3% below fair value)
Industry Position: 53.7% above the Healthcare Providers & Services median (#291 of 668)
No single metric tells the full story. See the SDGCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sundrug Co Ltd is a Japanese-based company engaged in the operation of drug stores and discount stores. The Group operates through two segments: the Drug Store Business, which mainly sells pharmaceuticals, cosmetics, and daily necessities, and the Discount Store Business, which mainly sells food products, household goods, and other related items. It generates the majority of its revenue from the Drugstore business segment.
82GF Score
Get the complete analysis for SDGCF
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SDGCF has been successfully added to your 
